


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Recently Viewed
PATH
UiPath
TTEC
TTEC Holdings
HRTX
Heron Therapeutics I
REAL
The RealRea
AGI
Alamos Gold
Most Trending
-1.71%
+2.67%
+1.12%
-4.33%
-0.38%
PATH
UiPath
$15.21
Strengths

Earnings are forecast to grow

Investors confidence is positive

Upgraded on attractively valued
PATH Price Performance
$15.96 (-4.70%)
$15.93 (-4.52%)
$11.14 (+36.54%)
$14.22 (+6.96%)
PATH has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

PATH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
PATH Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PATH Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
PATH
UiPath
15.21
-1.11%
TTEC
TTEC Holdings
3.41
+4.60%
HRTX
Heron Therapeutics I
1.50
+0.34%
REAL
The RealRea
16.67
+0.42%
AGI
Alamos Gold
40.01
-6.86%
What is PATH current stock price?
What are PATH stock strengths?
What is PATH Risk Level?
What is PATH market cap and volume?
What is PATH current Stock IQ?
Should I buy PATH stock right now?
Is PATH a Strong Buy right now?
What does a 'Strong Buy' rating mean for PATH?
What does a 'Strong Sell' rating mean for PATH?
What factors influence PATH's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Recently Viewed
PATH
UiPath
TTEC
TTEC Holdings
HRTX
Heron Therapeutics I
REAL
The RealRea
AGI
Alamos Gold
Most Trending
-1.71%
+2.67%
+1.12%
-4.33%
-0.38%
PATH
UiPath
Current Price
$15.21
PATH Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Investors confidence is positive

Upgraded on attractively valued
Recently Viewed
PATH
UiPath
15.21
-1.11%
TTEC
TTEC Holdings
3.41
+4.60%
HRTX
Heron Therapeutics I
1.50
+0.34%
REAL
The RealRea
16.67
+0.42%
AGI
Alamos Gold
40.01
-6.86%

PATH Price Performance
$15.96 (-4.70%)
$15.93 (-4.52%)
$11.14 (+36.54%)
$14.22 (+6.96%)
PATH Analysts Opinion
PATH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
PATH Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PATH Street Sentiment is extremely bullish and have negative views on the near-term outlook
PATH has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
PATH Latest Analysis
UiPath Inc. (PATH) Presents at 28th Annual Needham Growth Conference Transcript.
Tue Jan 13, 2026
Tradr Launches Leveraged ETFs on Critical Metals Ondas Holdings UiPath and USA Rare Earth. Suite includes two first-to market funds CRMX and PATX that seek to provide 200% long exposure a provider of ETFs designed for sophisticated investors and professional traders today launched four new single stock leveraged ETFs. The funds seek to deliver twice (200%) the daily performance of a specific underlying stock. Listed on Cboe these ETFs represent Tradr'.s first ETF launches of 2026.The followi
Tue Jan 13, 2026
How Do Investors Really Feel About UiPath Inc?. PATH) short interest as a percent of float has fallen 4.16% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will ...
Wed Jan 7, 2026
UiPath Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It. Recently Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
Tue Dec 30, 2025
Morgan Stanley Upgrades UiPath (PATH) Following Strong FQ3 2026 Earnings Beat and Profitability Milestone. UiPath Inc. (NYSE:PATH) is one of the AI stocks under $20 to buy now. On December 9 Morgan Stanley analyst Sanjit Singh raised the firms price target on UiPath to $19 from $15 with an Equal Weight rating on the shares. This sentiment was posted after the firm adjusted estimates and valuations among its software [….]
Mon Dec 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PATH Stock trends
PATH Stock performance
PATH Stock analysis
PATH investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.